Global Recombinant Erythropoietin Drugs Market Growth 2023-2028

Report ID: 1332683 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Recombinant Erythropoietin Drugs Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Recombinant Erythropoietin Drugs by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Recombinant Erythropoietin Drugs by Country/Region, 2017, 2022 & 2028
    2.2 Recombinant Erythropoietin Drugs Segment by Type
        2.2.1 rhEPO
        2.2.2 Erythropoiesis-Stimulating Agents (ESA)
    2.3 Recombinant Erythropoietin Drugs Sales by Type
        2.3.1 Global Recombinant Erythropoietin Drugs Sales Market Share by Type (2017-2022)
        2.3.2 Global Recombinant Erythropoietin Drugs Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Recombinant Erythropoietin Drugs Sale Price by Type (2017-2022)
    2.4 Recombinant Erythropoietin Drugs Segment by Application
        2.4.1 Chronic Kidney Disease
        2.4.2 Cancer Related Anemia
        2.4.3 Others
    2.5 Recombinant Erythropoietin Drugs Sales by Application
        2.5.1 Global Recombinant Erythropoietin Drugs Sale Market Share by Application (2017-2022)
        2.5.2 Global Recombinant Erythropoietin Drugs Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Recombinant Erythropoietin Drugs Sale Price by Application (2017-2022)
3 Global Recombinant Erythropoietin Drugs by Company
    3.1 Global Recombinant Erythropoietin Drugs Breakdown Data by Company
        3.1.1 Global Recombinant Erythropoietin Drugs Annual Sales by Company (2020-2022)
        3.1.2 Global Recombinant Erythropoietin Drugs Sales Market Share by Company (2020-2022)
    3.2 Global Recombinant Erythropoietin Drugs Annual Revenue by Company (2020-2022)
        3.2.1 Global Recombinant Erythropoietin Drugs Revenue by Company (2020-2022)
        3.2.2 Global Recombinant Erythropoietin Drugs Revenue Market Share by Company (2020-2022)
    3.3 Global Recombinant Erythropoietin Drugs Sale Price by Company
    3.4 Key Manufacturers Recombinant Erythropoietin Drugs Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Recombinant Erythropoietin Drugs Product Location Distribution
        3.4.2 Players Recombinant Erythropoietin Drugs Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Recombinant Erythropoietin Drugs by Geographic Region
    4.1 World Historic Recombinant Erythropoietin Drugs Market Size by Geographic Region (2017-2022)
        4.1.1 Global Recombinant Erythropoietin Drugs Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Recombinant Erythropoietin Drugs Annual Revenue by Geographic Region
    4.2 World Historic Recombinant Erythropoietin Drugs Market Size by Country/Region (2017-2022)
        4.2.1 Global Recombinant Erythropoietin Drugs Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Recombinant Erythropoietin Drugs Annual Revenue by Country/Region
    4.3 Americas Recombinant Erythropoietin Drugs Sales Growth
    4.4 APAC Recombinant Erythropoietin Drugs Sales Growth
    4.5 Europe Recombinant Erythropoietin Drugs Sales Growth
    4.6 Middle East & Africa Recombinant Erythropoietin Drugs Sales Growth
5 Americas
    5.1 Americas Recombinant Erythropoietin Drugs Sales by Country
        5.1.1 Americas Recombinant Erythropoietin Drugs Sales by Country (2017-2022)
        5.1.2 Americas Recombinant Erythropoietin Drugs Revenue by Country (2017-2022)
    5.2 Americas Recombinant Erythropoietin Drugs Sales by Type
    5.3 Americas Recombinant Erythropoietin Drugs Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Recombinant Erythropoietin Drugs Sales by Region
        6.1.1 APAC Recombinant Erythropoietin Drugs Sales by Region (2017-2022)
        6.1.2 APAC Recombinant Erythropoietin Drugs Revenue by Region (2017-2022)
    6.2 APAC Recombinant Erythropoietin Drugs Sales by Type
    6.3 APAC Recombinant Erythropoietin Drugs Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Recombinant Erythropoietin Drugs by Country
        7.1.1 Europe Recombinant Erythropoietin Drugs Sales by Country (2017-2022)
        7.1.2 Europe Recombinant Erythropoietin Drugs Revenue by Country (2017-2022)
    7.2 Europe Recombinant Erythropoietin Drugs Sales by Type
    7.3 Europe Recombinant Erythropoietin Drugs Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Recombinant Erythropoietin Drugs by Country
        8.1.1 Middle East & Africa Recombinant Erythropoietin Drugs Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Recombinant Erythropoietin Drugs Revenue by Country (2017-2022)
    8.2 Middle East & Africa Recombinant Erythropoietin Drugs Sales by Type
    8.3 Middle East & Africa Recombinant Erythropoietin Drugs Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Recombinant Erythropoietin Drugs
    10.3 Manufacturing Process Analysis of Recombinant Erythropoietin Drugs
    10.4 Industry Chain Structure of Recombinant Erythropoietin Drugs
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Recombinant Erythropoietin Drugs Distributors
    11.3 Recombinant Erythropoietin Drugs Customer
12 World Forecast Review for Recombinant Erythropoietin Drugs by Geographic Region
    12.1 Global Recombinant Erythropoietin Drugs Market Size Forecast by Region
        12.1.1 Global Recombinant Erythropoietin Drugs Forecast by Region (2023-2028)
        12.1.2 Global Recombinant Erythropoietin Drugs Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Recombinant Erythropoietin Drugs Forecast by Type
    12.7 Global Recombinant Erythropoietin Drugs Forecast by Application
13 Key Players Analysis
    13.1 Amgen
        13.1.1 Amgen Company Information
        13.1.2 Amgen Recombinant Erythropoietin Drugs Product Offered
        13.1.3 Amgen Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Amgen Main Business Overview
        13.1.5 Amgen Latest Developments
    13.2 Johnson & Johnson
        13.2.1 Johnson & Johnson Company Information
        13.2.2 Johnson & Johnson Recombinant Erythropoietin Drugs Product Offered
        13.2.3 Johnson & Johnson Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Johnson & Johnson Main Business Overview
        13.2.5 Johnson & Johnson Latest Developments
    13.3 Kyowa Hakko Kirin
        13.3.1 Kyowa Hakko Kirin Company Information
        13.3.2 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product Offered
        13.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Kyowa Hakko Kirin Main Business Overview
        13.3.5 Kyowa Hakko Kirin Latest Developments
    13.4 Roche
        13.4.1 Roche Company Information
        13.4.2 Roche Recombinant Erythropoietin Drugs Product Offered
        13.4.3 Roche Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Roche Main Business Overview
        13.4.5 Roche Latest Developments
    13.5 3SBio Group
        13.5.1 3SBio Group Company Information
        13.5.2 3SBio Group Recombinant Erythropoietin Drugs Product Offered
        13.5.3 3SBio Group Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 3SBio Group Main Business Overview
        13.5.5 3SBio Group Latest Developments
    13.6 Celltrion, Inc
        13.6.1 Celltrion, Inc Company Information
        13.6.2 Celltrion, Inc Recombinant Erythropoietin Drugs Product Offered
        13.6.3 Celltrion, Inc Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Celltrion, Inc Main Business Overview
        13.6.5 Celltrion, Inc Latest Developments
    13.7 Teva Pharmaceutical Industries Ltd
        13.7.1 Teva Pharmaceutical Industries Ltd Company Information
        13.7.2 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Offered
        13.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Teva Pharmaceutical Industries Ltd Main Business Overview
        13.7.5 Teva Pharmaceutical Industries Ltd Latest Developments
    13.8 F. Hoffmann-La Roche Ltd
        13.8.1 F. Hoffmann-La Roche Ltd Company Information
        13.8.2 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product Offered
        13.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 F. Hoffmann-La Roche Ltd Main Business Overview
        13.8.5 F. Hoffmann-La Roche Ltd Latest Developments
    13.9 LG Life Sciences Ltd
        13.9.1 LG Life Sciences Ltd Company Information
        13.9.2 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product Offered
        13.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 LG Life Sciences Ltd Main Business Overview
        13.9.5 LG Life Sciences Ltd Latest Developments
    13.10 Biocon Limited
        13.10.1 Biocon Limited Company Information
        13.10.2 Biocon Limited Recombinant Erythropoietin Drugs Product Offered
        13.10.3 Biocon Limited Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Biocon Limited Main Business Overview
        13.10.5 Biocon Limited Latest Developments
    13.11 Intas Pharmaceuticals Ltd
        13.11.1 Intas Pharmaceuticals Ltd Company Information
        13.11.2 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product Offered
        13.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Intas Pharmaceuticals Ltd Main Business Overview
        13.11.5 Intas Pharmaceuticals Ltd Latest Developments
    13.12 Sun Pharmaceutical Industries Ltd
        13.12.1 Sun Pharmaceutical Industries Ltd Company Information
        13.12.2 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Offered
        13.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Sun Pharmaceutical Industries Ltd Main Business Overview
        13.12.5 Sun Pharmaceutical Industries Ltd Latest Developments
    13.13 Dr. Reddy's Laboratories Ltd
        13.13.1 Dr. Reddy's Laboratories Ltd Company Information
        13.13.2 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Product Offered
        13.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Dr. Reddy's Laboratories Ltd Main Business Overview
        13.13.5 Dr. Reddy's Laboratories Ltd Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Recombinant Erythropoietin Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Recombinant Erythropoietin Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of rhEPO
    Table 4. Major Players of Erythropoiesis-Stimulating Agents (ESA)
    Table 5. Global Recombinant Erythropoietin Drugs Sales by Type (2017-2022) & (KG)
    Table 6. Global Recombinant Erythropoietin Drugs Sales Market Share by Type (2017-2022)
    Table 7. Global Recombinant Erythropoietin Drugs Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Recombinant Erythropoietin Drugs Revenue Market Share by Type (2017-2022)
    Table 9. Global Recombinant Erythropoietin Drugs Sale Price by Type (2017-2022) & (USD/g)
    Table 10. Global Recombinant Erythropoietin Drugs Sales by Application (2017-2022) & (KG)
    Table 11. Global Recombinant Erythropoietin Drugs Sales Market Share by Application (2017-2022)
    Table 12. Global Recombinant Erythropoietin Drugs Revenue by Application (2017-2022)
    Table 13. Global Recombinant Erythropoietin Drugs Revenue Market Share by Application (2017-2022)
    Table 14. Global Recombinant Erythropoietin Drugs Sale Price by Application (2017-2022) & (USD/g)
    Table 15. Global Recombinant Erythropoietin Drugs Sales by Company (2020-2022) & (KG)
    Table 16. Global Recombinant Erythropoietin Drugs Sales Market Share by Company (2020-2022)
    Table 17. Global Recombinant Erythropoietin Drugs Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Recombinant Erythropoietin Drugs Revenue Market Share by Company (2020-2022)
    Table 19. Global Recombinant Erythropoietin Drugs Sale Price by Company (2020-2022) & (USD/g)
    Table 20. Key Manufacturers Recombinant Erythropoietin Drugs Producing Area Distribution and Sales Area
    Table 21. Players Recombinant Erythropoietin Drugs Products Offered
    Table 22. Recombinant Erythropoietin Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Recombinant Erythropoietin Drugs Sales by Geographic Region (2017-2022) & (KG)
    Table 26. Global Recombinant Erythropoietin Drugs Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Recombinant Erythropoietin Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Recombinant Erythropoietin Drugs Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Recombinant Erythropoietin Drugs Sales by Country/Region (2017-2022) & (KG)
    Table 30. Global Recombinant Erythropoietin Drugs Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Recombinant Erythropoietin Drugs Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Recombinant Erythropoietin Drugs Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Recombinant Erythropoietin Drugs Sales by Country (2017-2022) & (KG)
    Table 34. Americas Recombinant Erythropoietin Drugs Sales Market Share by Country (2017-2022)
    Table 35. Americas Recombinant Erythropoietin Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Recombinant Erythropoietin Drugs Revenue Market Share by Country (2017-2022)
    Table 37. Americas Recombinant Erythropoietin Drugs Sales by Type (2017-2022) & (KG)
    Table 38. Americas Recombinant Erythropoietin Drugs Sales Market Share by Type (2017-2022)
    Table 39. Americas Recombinant Erythropoietin Drugs Sales by Application (2017-2022) & (KG)
    Table 40. Americas Recombinant Erythropoietin Drugs Sales Market Share by Application (2017-2022)
    Table 41. APAC Recombinant Erythropoietin Drugs Sales by Region (2017-2022) & (KG)
    Table 42. APAC Recombinant Erythropoietin Drugs Sales Market Share by Region (2017-2022)
    Table 43. APAC Recombinant Erythropoietin Drugs Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Recombinant Erythropoietin Drugs Revenue Market Share by Region (2017-2022)
    Table 45. APAC Recombinant Erythropoietin Drugs Sales by Type (2017-2022) & (KG)
    Table 46. APAC Recombinant Erythropoietin Drugs Sales Market Share by Type (2017-2022)
    Table 47. APAC Recombinant Erythropoietin Drugs Sales by Application (2017-2022) & (KG)
    Table 48. APAC Recombinant Erythropoietin Drugs Sales Market Share by Application (2017-2022)
    Table 49. Europe Recombinant Erythropoietin Drugs Sales by Country (2017-2022) & (KG)
    Table 50. Europe Recombinant Erythropoietin Drugs Sales Market Share by Country (2017-2022)
    Table 51. Europe Recombinant Erythropoietin Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Recombinant Erythropoietin Drugs Revenue Market Share by Country (2017-2022)
    Table 53. Europe Recombinant Erythropoietin Drugs Sales by Type (2017-2022) & (KG)
    Table 54. Europe Recombinant Erythropoietin Drugs Sales Market Share by Type (2017-2022)
    Table 55. Europe Recombinant Erythropoietin Drugs Sales by Application (2017-2022) & (KG)
    Table 56. Europe Recombinant Erythropoietin Drugs Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Recombinant Erythropoietin Drugs Sales by Country (2017-2022) & (KG)
    Table 58. Middle East & Africa Recombinant Erythropoietin Drugs Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Recombinant Erythropoietin Drugs Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Recombinant Erythropoietin Drugs Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Recombinant Erythropoietin Drugs Sales by Type (2017-2022) & (KG)
    Table 62. Middle East & Africa Recombinant Erythropoietin Drugs Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Recombinant Erythropoietin Drugs Sales by Application (2017-2022) & (KG)
    Table 64. Middle East & Africa Recombinant Erythropoietin Drugs Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Recombinant Erythropoietin Drugs
    Table 66. Key Market Challenges & Risks of Recombinant Erythropoietin Drugs
    Table 67. Key Industry Trends of Recombinant Erythropoietin Drugs
    Table 68. Recombinant Erythropoietin Drugs Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Recombinant Erythropoietin Drugs Distributors List
    Table 71. Recombinant Erythropoietin Drugs Customer List
    Table 72. Global Recombinant Erythropoietin Drugs Sales Forecast by Region (2023-2028) & (KG)
    Table 73. Global Recombinant Erythropoietin Drugs Sales Market Forecast by Region
    Table 74. Global Recombinant Erythropoietin Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Recombinant Erythropoietin Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Recombinant Erythropoietin Drugs Sales Forecast by Country (2023-2028) & (KG)
    Table 77. Americas Recombinant Erythropoietin Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Recombinant Erythropoietin Drugs Sales Forecast by Region (2023-2028) & (KG)
    Table 79. APAC Recombinant Erythropoietin Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Recombinant Erythropoietin Drugs Sales Forecast by Country (2023-2028) & (KG)
    Table 81. Europe Recombinant Erythropoietin Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Recombinant Erythropoietin Drugs Sales Forecast by Country (2023-2028) & (KG)
    Table 83. Middle East & Africa Recombinant Erythropoietin Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Recombinant Erythropoietin Drugs Sales Forecast by Type (2023-2028) & (KG)
    Table 85. Global Recombinant Erythropoietin Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Recombinant Erythropoietin Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Recombinant Erythropoietin Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Recombinant Erythropoietin Drugs Sales Forecast by Application (2023-2028) & (KG)
    Table 89. Global Recombinant Erythropoietin Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Recombinant Erythropoietin Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Recombinant Erythropoietin Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Amgen Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 93. Amgen Recombinant Erythropoietin Drugs Product Offered
    Table 94. Amgen Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 95. Amgen Main Business
    Table 96. Amgen Latest Developments
    Table 97. Johnson & Johnson Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 98. Johnson & Johnson Recombinant Erythropoietin Drugs Product Offered
    Table 99. Johnson & Johnson Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 100. Johnson & Johnson Main Business
    Table 101. Johnson & Johnson Latest Developments
    Table 102. Kyowa Hakko Kirin Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 103. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Product Offered
    Table 104. Kyowa Hakko Kirin Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 105. Kyowa Hakko Kirin Main Business
    Table 106. Kyowa Hakko Kirin Latest Developments
    Table 107. Roche Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 108. Roche Recombinant Erythropoietin Drugs Product Offered
    Table 109. Roche Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 110. Roche Main Business
    Table 111. Roche Latest Developments
    Table 112. 3SBio Group Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 113. 3SBio Group Recombinant Erythropoietin Drugs Product Offered
    Table 114. 3SBio Group Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 115. 3SBio Group Main Business
    Table 116. 3SBio Group Latest Developments
    Table 117. Celltrion, Inc Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 118. Celltrion, Inc Recombinant Erythropoietin Drugs Product Offered
    Table 119. Celltrion, Inc Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 120. Celltrion, Inc Main Business
    Table 121. Celltrion, Inc Latest Developments
    Table 122. Teva Pharmaceutical Industries Ltd Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 123. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Offered
    Table 124. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 125. Teva Pharmaceutical Industries Ltd Main Business
    Table 126. Teva Pharmaceutical Industries Ltd Latest Developments
    Table 127. F. Hoffmann-La Roche Ltd Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 128. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Product Offered
    Table 129. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 130. F. Hoffmann-La Roche Ltd Main Business
    Table 131. F. Hoffmann-La Roche Ltd Latest Developments
    Table 132. LG Life Sciences Ltd Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 133. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Product Offered
    Table 134. LG Life Sciences Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 135. LG Life Sciences Ltd Main Business
    Table 136. LG Life Sciences Ltd Latest Developments
    Table 137. Biocon Limited Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 138. Biocon Limited Recombinant Erythropoietin Drugs Product Offered
    Table 139. Biocon Limited Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 140. Biocon Limited Main Business
    Table 141. Biocon Limited Latest Developments
    Table 142. Intas Pharmaceuticals Ltd Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 143. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Product Offered
    Table 144. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 145. Intas Pharmaceuticals Ltd Main Business
    Table 146. Intas Pharmaceuticals Ltd Latest Developments
    Table 147. Sun Pharmaceutical Industries Ltd Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 148. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Product Offered
    Table 149. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 150. Sun Pharmaceutical Industries Ltd Main Business
    Table 151. Sun Pharmaceutical Industries Ltd Latest Developments
    Table 152. Dr. Reddy's Laboratories Ltd Basic Information, Recombinant Erythropoietin Drugs Manufacturing Base, Sales Area and Its Competitors
    Table 153. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Product Offered
    Table 154. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Drugs Sales (KG), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2022)
    Table 155. Dr. Reddy's Laboratories Ltd Main Business
    Table 156. Dr. Reddy's Laboratories Ltd Latest Developments
List of Figures
    Figure 1. Picture of Recombinant Erythropoietin Drugs
    Figure 2. Recombinant Erythropoietin Drugs Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Recombinant Erythropoietin Drugs Sales Growth Rate 2017-2028 (KG)
    Figure 7. Global Recombinant Erythropoietin Drugs Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Recombinant Erythropoietin Drugs Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of rhEPO
    Figure 10. Product Picture of Erythropoiesis-Stimulating Agents (ESA)
    Figure 11. Global Recombinant Erythropoietin Drugs Sales Market Share by Type in 2021
    Figure 12. Global Recombinant Erythropoietin Drugs Revenue Market Share by Type (2017-2022)
    Figure 13. Recombinant Erythropoietin Drugs Consumed in Chronic Kidney Disease
    Figure 14. Global Recombinant Erythropoietin Drugs Market: Chronic Kidney Disease (2017-2022) & (KG)
    Figure 15. Recombinant Erythropoietin Drugs Consumed in Cancer Related Anemia
    Figure 16. Global Recombinant Erythropoietin Drugs Market: Cancer Related Anemia (2017-2022) & (KG)
    Figure 17. Recombinant Erythropoietin Drugs Consumed in Others
    Figure 18. Global Recombinant Erythropoietin Drugs Market: Others (2017-2022) & (KG)
    Figure 19. Global Recombinant Erythropoietin Drugs Sales Market Share by Application (2017-2022)
    Figure 20. Global Recombinant Erythropoietin Drugs Revenue Market Share by Application in 2021
    Figure 21. Recombinant Erythropoietin Drugs Revenue Market by Company in 2021 ($ Million)
    Figure 22. Global Recombinant Erythropoietin Drugs Revenue Market Share by Company in 2021
    Figure 23. Global Recombinant Erythropoietin Drugs Sales Market Share by Geographic Region (2017-2022)
    Figure 24. Global Recombinant Erythropoietin Drugs Revenue Market Share by Geographic Region in 2021
    Figure 25. Global Recombinant Erythropoietin Drugs Sales Market Share by Region (2017-2022)
    Figure 26. Global Recombinant Erythropoietin Drugs Revenue Market Share by Country/Region in 2021
    Figure 27. Americas Recombinant Erythropoietin Drugs Sales 2017-2022 (KG)
    Figure 28. Americas Recombinant Erythropoietin Drugs Revenue 2017-2022 ($ Millions)
    Figure 29. APAC Recombinant Erythropoietin Drugs Sales 2017-2022 (KG)
    Figure 30. APAC Recombinant Erythropoietin Drugs Revenue 2017-2022 ($ Millions)
    Figure 31. Europe Recombinant Erythropoietin Drugs Sales 2017-2022 (KG)
    Figure 32. Europe Recombinant Erythropoietin Drugs Revenue 2017-2022 ($ Millions)
    Figure 33. Middle East & Africa Recombinant Erythropoietin Drugs Sales 2017-2022 (KG)
    Figure 34. Middle East & Africa Recombinant Erythropoietin Drugs Revenue 2017-2022 ($ Millions)
    Figure 35. Americas Recombinant Erythropoietin Drugs Sales Market Share by Country in 2021
    Figure 36. Americas Recombinant Erythropoietin Drugs Revenue Market Share by Country in 2021
    Figure 37. United States Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Canada Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Mexico Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Brazil Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 41. APAC Recombinant Erythropoietin Drugs Sales Market Share by Region in 2021
    Figure 42. APAC Recombinant Erythropoietin Drugs Revenue Market Share by Regions in 2021
    Figure 43. China Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Japan Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 45. South Korea Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Southeast Asia Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 47. India Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Australia Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Europe Recombinant Erythropoietin Drugs Sales Market Share by Country in 2021
    Figure 50. Europe Recombinant Erythropoietin Drugs Revenue Market Share by Country in 2021
    Figure 51. Germany Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 52. France Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 53. UK Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Italy Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Russia Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Middle East & Africa Recombinant Erythropoietin Drugs Sales Market Share by Country in 2021
    Figure 57. Middle East & Africa Recombinant Erythropoietin Drugs Revenue Market Share by Country in 2021
    Figure 58. Egypt Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Africa Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Israel Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Turkey Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country Recombinant Erythropoietin Drugs Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Manufacturing Cost Structure Analysis of Recombinant Erythropoietin Drugs in 2021
    Figure 64. Manufacturing Process Analysis of Recombinant Erythropoietin Drugs
    Figure 65. Industry Chain Structure of Recombinant Erythropoietin Drugs
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Recombinant Erythropoietin Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Recombinant Erythropoietin Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Recombinant Erythropoietin Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports